Medtronic plc (MDT) : During the past 4 weeks, traders have been relatively bearish on Medtronic plc (MDT), hence the stock is down -3.83% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -1.04% relative to the S&P 500. The 4-week change in the price of the stock is -1.44% and the stock has fallen -0.62% in the past 1 week.
Medtronic plc (NYSE:MDT): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $86.83 and $86.74 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $87.14. The buying momentum continued till the end and the stock did not give up its gains. It closed at $87.09, notching a gain of 0.38% for the day. The total traded volume was 3,031,406 . The stock had closed at $86.76 on the previous day.
The stock has recorded a 20-day Moving Average of 0.97% and the 50-Day Moving Average is 1.84%. Medtronic plc is up 9.76% in the last 3-month period. Year-to-Date the stock performance stands at 14.36%.
Medtronic plc (MDT) : Average target price received by Medtronic plc (MDT) is $89.54 with an expected standard deviation of $11.5. The most aggressive target on the stock is $104, whereas the most downbeat target is $56. 14 financial analysts are currently covering the stock.
Medtronic plc (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic, Inc. is a subsidiary of the Company.